Search 

Liverpool City Region is a UK government Health and Life Sciences Innovation Zone, as well as being formally recognises as a leading hub for vaccine discovery, development and manufacturing. Explore exceptional opportunities in the Liverpool City Region, which features one of Europe’s largest concentrations of biomanufacturing and pharmaceutical clusters. Here, global brands are at the forefront of innovation, advancing everything from cutting-edge clinical research to large-scale production of pharmaceuticals, vaccines, and biologics. Key highlights of our vibrant ecosystem include: Europe’s largest biomanufacturing cluster. A leading UK hub for vaccine discovery, development, and manufacturing, recognized by the UK government. The highest number of specialist hospitals outside of London. Home to the UK Centre for Tropical and Infectious Prevention and Control

Established in 1994 and primarily owned by the North West Lung Centre charity, the Medicines Evaluation Unit (MEU) is a leading clinical research organisation specialising in pioneering respiratory research and early-phase exploratory trials. Recognised with multiple industry awards, including the Queen’s Award for Enterprise and "Clinical Trial Research Team of the Year," the MEU partners with most major global CROs and pharmaceutical companies. Critically, we also offer a comprehensive, single-site solution for small biotech firms entering clinical trials for the first time. Through our sister company, CRO-Solutions, and our proprietary I.C.A.R.U.S. database of over 43,000 pre-screened volunteers, the MEU ensures immediate trial start-up and expert, hands-on support. This is across all stages of clinical development, delivering efficient, cost-effective solutions for sponsors worldwide.